Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts

PURPOSE: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin (Cb) to anthracycline/taxane chemotherapy improves pathological complete response (pCR) in triple negative breast cancer (TNBC). Effectiveness of anthracycline-free, platinum combinations in TNBC is not well known. Her...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, Jose Angel, Ward, Claire, Connor, Carol S., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Augusti, Picornell, Antoni C., del Monte-Millán, Maria, Gonzalez-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortes, Javier, Fuentes, Hugo, Bretel, Denisse, Márquez-Rodas, Iván, Perou, Charles M., Wagner, Jamie L., Mammen, Joshua V., McGinness, Marilee K., Klemp, Jennifer R., Amin, Amanda L., Fabian, Carol J., Heldstab, Jaimie, Godwin, Andrew K., Jensen, Roy A., Kimler, Bruce F., Khan, Qamar J., Martin, Miguel
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156592/
https://ncbi.nlm.nih.gov/pubmed/27301700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0162
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki